These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32386701)

  • 1. Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome.
    Anguelova GV; Vlak MHM; Kurvers AGY; Rijsman RM
    Sleep Med Clin; 2020 Jun; 15(2):277-288. PubMed ID: 32386701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome.
    Anguelova GV; Vlak MHM; Kurvers AGY; Rijsman RM
    Sleep Med Clin; 2018 Jun; 13(2):219-230. PubMed ID: 29759272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
    Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
    Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
    Winkelman JW; Armstrong MJ; Allen RP; Chaudhuri KR; Ondo W; Trenkwalder C; Zee PC; Gronseth GS; Gloss D; Zesiewicz T
    Neurology; 2016 Dec; 87(24):2585-2593. PubMed ID: 27856776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restless legs syndrome: nonpharmacologic and pharmacologic treatments.
    Winkelman JW; Allen RP; Tenzer P; Hening W
    Geriatrics; 2007 Oct; 62(10):13-6. PubMed ID: 17922563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).
    Garcia-Borreguero D; Cano-Pumarega I; Marulanda R
    Sleep Med Rev; 2018 Oct; 41():50-60. PubMed ID: 29602660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension.
    Trenkwalder C; Beneš H; Grote L; García-Borreguero D; Högl B; Hopp M; Bosse B; Oksche A; Reimer K; Winkelmann J; Allen RP; Kohnen R;
    Lancet Neurol; 2013 Dec; 12(12):1141-50. PubMed ID: 24140442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancing synthetic therapies for the treatment of restless legs syndrome.
    de Biase S; Pellitteri G; Gigli GL; Valente M
    Expert Opin Pharmacother; 2019 Nov; 20(16):1971-1980. PubMed ID: 31424287
    [No Abstract]   [Full Text] [Related]  

  • 9. French consensus: Treatment of newly diagnosed restless legs syndrome.
    Limousin N; Flamand M; Schröder C; Charley Monaca C
    Rev Neurol (Paris); 2018; 174(7-8):515-521. PubMed ID: 30054010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy for restless legs syndrome.
    Ferini-Strambi L; Marelli S
    Expert Opin Pharmacother; 2014 Jun; 15(8):1127-38. PubMed ID: 24745717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. French consensus: Augmentation syndrome in restless legs syndrome.
    Leu-Semenescu S; Petiau C; Charley Monaca C; Dauvilliers Y
    Rev Neurol (Paris); 2018; 174(7-8):532-539. PubMed ID: 30055794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome.
    Wanner V; Garcia Malo C; Romero S; Cano-Pumarega I; García-Borreguero D
    Adv Pharmacol; 2019; 84():187-205. PubMed ID: 31229171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From bench to bedside: An overview of rotigotine for the treatment of restless legs syndrome.
    Bogan RK
    Clin Ther; 2014 Mar; 36(3):436-55. PubMed ID: 24636821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restless Legs Syndrome: Contemporary Diagnosis and Treatment.
    Gossard TR; Trotti LM; Videnovic A; St Louis EK
    Neurotherapeutics; 2021 Jan; 18(1):140-155. PubMed ID: 33880737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targinact for restless legs syndrome.
    Drug Ther Bull; 2016 Apr; 54(4):42-5. PubMed ID: 27079737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Pressure on Abductor Hallucis and Flexor Hallucis Brevis Muscles to Manage Moderate to Severe Primary Restless Legs Syndrome.
    Kuhn PJ; Olson DJ; Sullivan JP
    J Am Osteopath Assoc; 2016 Jul; 116(7):440-50. PubMed ID: 27367949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic advances in restless legs syndrome (RLS).
    Högl B; Comella C
    Mov Disord; 2015 Sep; 30(11):1574-9. PubMed ID: 26371624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome.
    Anguelova GV; Vlak MHM; Kurvers AGY; Rijsman RM
    Sleep Med Clin; 2022 Sep; 17(3):407-419. PubMed ID: 36150803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on the treatment of Restless Legs Syndrome/Willis-Ekbom Disease: prospects and challenges.
    Zucconi M; Galbiati A; Rinaldi F; Casoni F; Ferini-Strambi L
    Expert Rev Neurother; 2018 Sep; 18(9):705-713. PubMed ID: 30095315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for the treatment of restless legs syndrome.
    Buchfuhrer MJ
    Neurotherapeutics; 2012 Oct; 9(4):776-90. PubMed ID: 22923001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.